Clinical Trial Update: A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia

View source ↗

Summary

This is a real-world clinical trial in Saudi Arabia evaluating guselkumab for ulcerative colitis and Crohn's disease, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Colitis, Ulcerative | Status: NOT_YET_RECRUITING